FOR PATIENTS · SOURCE READING
Targeted therapy
Source: Renal Cell Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview for Renal Cell Cancer / The following types of treatment are used:
Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. Your doctor may suggest biomarker tests to help predict your response to certain targeted therapy drugs. Learn more about Biomarker Testing for Cancer Treatment.
Source links and citations
Targeted therapies used to treat renal cell cancer include:
axitinib
Source links and citations
bevacizumab
Source links and citations
cabozantinib
Source links and citations
everolimus
Source links and citations
lenvatinib
Source links and citations
pazopanib
Source links and citations
sorafenib
Source links and citations
sunitinib
Source links and citations
temsirolimus
Source links and citations
tivozanib
Source links and citations
Learn more about Targeted Therapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle